You are now leaving the Viatris UK page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.
Viatris redefines the healthcare landscape through strong leadership
Thanks to their strong expertise, knowledge and strategic vision of our healthcare environment, our executive leadership team brings unmatached value to Viatris all over the world.
Executive Leadership Team
Scott A. Smith
Chief Executive Officer
Viatris chief executive officer Scott A. Smith is a deeply knowledgeable senior global biotechnology and pharmaceutical executive with more than 35 years of experience. He is a seasoned builder who possesses vast global commercial and pharmaceutical expertise and a proven ability to build, grow and manage large complex organizations. Before becoming Viatris’ CEO, Smith was President of BioAtla, Inc., a global biotechnology company focused on the development of Conditionally Active BiologicsTM (CAB) antibody therapeutics and was President and Chief Operating Officer of Celgene Corp. Scott is a member of Viatris board of directors.
